MSB 3.76% $1.03 mesoblast limited

"Itescu compares it to the development of monoclonal antibodies...

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    "Itescu compares it to the development of monoclonal antibodies in the 1990s. Today, virtually all pharmaceutical companies offer monoclonal antibody-based drugs"

    What Silviu is referring to here (guess only) is
    Genentech..the company that pioneered monoclonal antibodies in the 1990s.

    http://www.gene.com/media/press-releases/4841/1997-09-19/anti-ige-monoclonal-antibody-progresses-

    I say Genentech because this company was mentioned by him ( the other company being Regeneron)at the AGM as well as during the ABC interview - as the two US Biotech companies which MSB mostly aspires to parody and follow in their foot steps.

    For more info on Reneneron http://en.wikipedia.org/wiki/Regeneron
    http://www.regeneron.com/


    A aggressive statement by the Professor !
    One is a 28bn biotech listed on NASDADQ(REGN). The other(Genentech) was acquired by Roche for 46bn in 2009.

    And I say aggressive because MR no-hype Silviu NEVER allows himself to make these statements. It just shows you how well things are going at the Blaster ..(How many positive annoucements in the last 8 Weeks ?)

    And yours truly is so pleased to have shares in a company that has these aspirations and when all is said and done..in the end ...could be the next Regeneron(or Genentech).

    Thanks for the post Vinny..really has me thinking

    Good Luck to ALL holders.
    Please DYOR.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.